Pulmatrix PULM
NASDAQ PULM
$1.50 0.00 (-0.33%)
As of: Aug 21, 2026 · 3:45 PM EDT

Pulmatrix (PULM) Accumulated Expenses (2014 - 2026)

Pulmatrix (PULM) posted Accumulated Expenses of $254000.0 for Q1 2026, up 345.61% sequentially from $57000.0 in Q4 2025, and up 3.25% YoY from $246000.0 in Q1 2025.

Pulmatrix (PULM) Accumulated Expenses (2014 - 2026) Analysis & Trends

Pulmatrix has reported Accumulated Expenses for 13 years, with the latest figure at $254000.0 in Q1 2026.

  • Quarterly Accumulated Expenses rose 3.25% year-over-year to $254000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $254000.0 (up 3.25% YoY) and the FY2025 annual result came in at $57000.0, up 50.0% from the prior year.
  • Accumulated Expenses grew to $254000.0 in Q1 2026 per PULM's latest filing, from $57000.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $2.7 million in Q3 2022 and troughed at $38000.0 in Q4 2024.
  • A 5-year average of $739882.4 and a median of $347000.0 in 2023 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2025: Accumulated Expenses surged 2567.96% in 2022, then tumbled 90.8% in 2025.
  • Over 5 years, Accumulated Expenses stood at $1.6 million in 2022, then sank by 78.82% to $347000.0 in 2023, then plunged by 89.05% to $38000.0 in 2024, then jumped by 50.0% to $57000.0 in 2025, then soared by 345.61% to $254000.0 in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $254000.0, $57000.0, and $180000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Pulmatrix 5.46 Mn 5.46 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 160,000.00
Mar 31, 2026 254,000.00
Dec 31, 2025 57,000.00
Sep 30, 2025 180,000.00
Jun 30, 2025 164,000.00
Mar 31, 2025 246,000.00
Dec 31, 2024 38,000.00
Sep 30, 2024 217,000.00
Jun 30, 2024 1.78 Mn
Mar 31, 2024 578,000.00
Dec 31, 2023 347,000.00
Sep 30, 2023 704,000.00
Jun 30, 2023 1.20 Mn
Mar 31, 2023 523,000.00
Dec 31, 2022 1.64 Mn
Sep 30, 2022 2.75 Mn
Jun 30, 2022 1.61 Mn
Mar 31, 2022 290,000.00
Dec 31, 2021 1.23 Mn
Sep 30, 2021 103,000.00